Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KATIE S MURRAY

Allopathic & Osteopathic Physicians Urology

NPI
1235372715
CMS profile
1640410
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$80,676.99

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $66,500.00 24
Travel and Lodging $7,608.76 38
Consulting Fee $3,973.00 4
Food and Beverage $2,450.23 66
Education $145.00 2

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KATIE S MURRAY

NPI 1235372715 · CMS profile ID 1640410

Allopathic & Osteopathic Physicians / Urology

NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1235372715?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KATIE S MURRAY, NPI 1235372715, CMS profile ID 1640410. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1235372715?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). KATIE S MURRAY, NPI 1235372715, CMS profile ID 1640410. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1235372715?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
KATIE S MURRAY, NPI 1235372715, CMS profile ID 1640410, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1235372715?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $80,676.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BOSTON SCIENTIFIC CORPORATION $41.9410/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777622541 CMS
UROGEN PHARMA, INC. $450.0010/11/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826679700 CMS
UROGEN PHARMA, INC. $14.1410/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826683721 CMS
BOSTON SCIENTIFIC CORPORATION $25.2510/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777622539 CMS
COLOPLAST CORP $12.6210/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293595 CMS
BOSTON SCIENTIFIC CORPORATION $17.6609/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777622545 CMS
Merck Sharp & Dohme Corporation $87.1009/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848596871 CMS
UROGEN PHARMA, INC. $141.3209/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826683475 CMS
COLOPLAST CORP $21.0709/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293583 CMS
UROGEN PHARMA, INC. $3,000.0009/15/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826678723 CMS
UROGEN PHARMA, INC. $1,200.0009/15/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688533 CMS
UROGEN PHARMA, INC. $8,300.0009/15/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688833 CMS
UROGEN PHARMA, INC. $55.1509/15/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688855 CMS
UROGEN PHARMA, INC. $6.8209/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688859 CMS
UROGEN PHARMA, INC. $187.6409/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826684115 CMS
UROGEN PHARMA, INC. $2,100.0009/01/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826685245 CMS
UROGEN PHARMA, INC. $39.9809/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826685417 CMS
UROGEN PHARMA, INC. $16.8009/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826685841 CMS
UROGEN PHARMA, INC. $14.3408/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826684947 CMS
UROGEN PHARMA, INC. $210.1508/25/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688837 CMS
COLOPLAST CORP $6.6508/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293573 CMS
UROGEN PHARMA, INC. $3.9708/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826680935 CMS
UROGEN PHARMA, INC. $758.0008/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688841 CMS
UROGEN PHARMA, INC. $50.0008/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688845 CMS
UROGEN PHARMA, INC. $25.0008/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688847 CMS
UROGEN PHARMA, INC. $50.1408/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826688851 CMS
Janssen Biotech, Inc. $90.0008/06/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788020409 CMS
UROGEN PHARMA, INC. $16.5308/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826680827 CMS
UROGEN PHARMA, INC. $552.7508/05/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826684443 CMS
UROGEN PHARMA, INC. $134.0008/05/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826684445 CMS
UROGEN PHARMA, INC. $134.0008/05/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826684449 CMS
UROGEN PHARMA, INC. $204.4508/04/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826685241 CMS
UROGEN PHARMA, INC. $150.0008/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826678537 CMS
UROGEN PHARMA, INC. $13.8908/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826682755 CMS
BOSTON SCIENTIFIC CORPORATION $66.2607/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777622543 CMS
UROGEN PHARMA, INC. $925.0007/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826679697 CMS
UROGEN PHARMA, INC. $2.8807/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826682411 CMS
UROGEN PHARMA, INC. $500.5007/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826678725 CMS
UROGEN PHARMA, INC. $12.8107/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826682403 CMS
UROGEN PHARMA, INC. $80.0007/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826685237 CMS
UROGEN PHARMA, INC. $12.7607/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826682383 CMS
COLOPLAST CORP $7.2907/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293557 CMS
COLOPLAST CORP $5.6007/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293715 CMS
UROGEN PHARMA, INC. $17.1407/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826677721 CMS
COLOPLAST CORP $2.4706/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293705 CMS
UROGEN PHARMA, INC. $11.7106/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826675385 CMS
UROGEN PHARMA, INC. $1,200.0006/09/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826676387 CMS
COLOPLAST CORP $3.3305/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844293531 CMS
UROGEN PHARMA, INC. $1,200.0005/26/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826686729 CMS
AstraZeneca Pharmaceuticals LP $2,148.0005/25/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829473579 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $438.16 8
PY2020 $2,718.30 9
PY2021 $80,676.99 134
PY2022 $28,238.61 71
PY2023 $127,461.41 145
PY2024 $124,348.67 129
PY2025 $210,924.73 208

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $39,502.30 10
PY2024 Principal investigator $76,350.81 12
PY2023 Principal investigator $53,815.48 18
PY2022 Principal investigator $3,309.63 11
PY2021 Principal investigator $27,847.52 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $325.00 08/28/2025 Non-covered Recipient Entity
New York Univ Schl Of Medcn
A Study of TAR200 in Combination With Cetrelimab TAR200 Alone or Cetrelimab Alone in Participants With Non Muscle Invasive Bladder Cancer NMIBC Unresponsive to Intravesical Bacillus Calmette Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy No dispute reported 06/30/2026 1175251847
Principal investigator 1 Janssen Research & Development, LLC $325.00 06/09/2025 Non-covered Recipient Entity
New York Univ Schl Of Medcn
A Study of TAR200 in Combination With Cetrelimab TAR200 Alone or Cetrelimab Alone in Participants With Non Muscle Invasive Bladder Cancer NMIBC Unresponsive to Intravesical Bacillus Calmette Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy No dispute reported 06/30/2026 1175251028
Principal investigator 1 SEAGEN INC. $662.30 05/26/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228827438
Principal investigator 1 SEAGEN INC. $1,000.00 05/26/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228827521
Principal investigator 1 SEAGEN INC. $2,850.00 05/26/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228827528
Principal investigator 1 SEAGEN INC. $8,100.00 05/26/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228828658
Principal investigator 1 SEAGEN INC. $500.00 05/21/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228827337
Principal investigator 1 SEAGEN INC. $24,915.00 05/16/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228828652
Principal investigator 1 SEAGEN INC. $500.00 05/16/2025 Non-covered Recipient Entity
NYU SCHOOL OF MEDICINE
A PHASE 2 MULTI COHORT OPEN LABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48 ADC IN SUBJECTS WITH HER2 EXPRESSING LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA No dispute reported 06/30/2026 1228828755
Principal investigator 1 Janssen Research & Development, LLC $325.00 03/17/2025 Non-covered Recipient Entity
New York Univ Schl Of Medcn
A Study of TAR200 in Combination With Cetrelimab TAR200 Alone or Cetrelimab Alone in Participants With Non Muscle Invasive Bladder Cancer NMIBC Unresponsive to Intravesical Bacillus Calmette Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy No dispute reported 06/30/2026 1175249678